People and Business News —1/23
People News
Yolanda Barbachano has been appointed as Head of Statistics for Quanticate.
Massive Bio announced the addition of two executives to its C-suite: Özgür “Oz” Huner as their first Chief Product Officer, and Erkan Terzi has been promoted to Chief Marketing Officer.
Encapsia announced the appointment of Francis Destin as its new Chief Operating Officer.
Dawn Sauro has been named as Elligo’s Chief Operating Officer.
Trialbee announced the addition of Kristopher Sarajian as their new Vice President of Marketing.
Greenphire has appointed Owen Newman as the Chief Financial Officer.
Emmes appointed Matt Honan as Vice President and Head of Corporate Development.
News
NNIT has received its recertification as a Veeva Premiere Services Partner – Development Cloud.
Recognition
Suvoda LLC surpassed 1,000 clinical trials in 2022 as study deployments surged nearly 20%.
Final ENLIVEN Trial Results Confirm Long-Term Benefit of Turalio in Tenosynovial Giant Cell Tumor
July 9th 2025In final data from the Phase III ENLIVEN study, Turalio (pexidartinib) demonstrated durable tumor responses and a consistent safety profile in patients with symptomatic TGCT not amenable to surgery.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FDA Expands Farapulse PFA Approval to Persistent AF After Strong ADVANTAGE AF Trial Results
July 7th 2025Boston Scientific’s Farapulse Pulsed Field Ablation System is now approved for treating persistent atrial fibrillation, following 12-month data from the ADVANTAGE AF trial showing strong safety, high freedom from AF, and no major complications.
Effect of AI/ML, Real World Evidence and Master Protocols on Trial Success
July 7th 2025How the application of artificial intelligence, broader use of real-world evidence, decentralized clinical trials, master protocols, and risk-based quality monitoring, together with strong ethical oversight and increased collaboration, are contributing to better healthcare delivery and strengthening the role of clinical research in driving global health progress.
